Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

NCT07493512 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Interventions

DRUG: Xaluritamig

Sponsor

Amgen